Prospects for the use of adeno-associated virus as a vector for human gene therapy

Human Gene Therapy

Volumn 5, Issue 7, 1994, Pages 793-801

  Kotin, Robert M ^a,b  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ADENO ASSOCIATED VIRUS; CLONING VECTOR; DNA INTEGRATION; GENE TARGETING; GENE THERAPY; HUMAN; NONHUMAN; REVIEW; VIRAL GENETICS; VIRUS RECOMBINANT;

ADENO-ASSOCIATED VIRUS;

EID: 0028170362     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1994.5.7-793     Document Type: Review

References (64)

1. BEATON, A., PALUMBO, P, and BERNS, K.I. (1989). Expression from the adeno-associated virus p5 and p19 promoters is negatively regulated in trans by the rep protein. J. Virol. 63, 4450-4454.
2. BECERRA, S.P., KOCZOT, F., FABISCH, P., and ROSE, J.A. (1988). Synthesis of adeno-associated virus structural proteins requires both alternative mRNA splicing and alternative initiations from a single transcript J. Virol. 62, 2745-2754.
3. BERNS, K.I. (1990). Parvovirusreplication. Microbiol. Rev. 54, 316-329.
4. BERNS, K.I., KOTIN, R.M., and LABOW, M.A. (1988). Regulation of adeno-associated virus DNA replication. Biochem. Biophys. Acta 951, 425-429
5. BOHENZKY, R.A, LEFEBVRE, R.B , and BERNS, K.I. (1988). Sequence and symmetry requirements within the internal palmdromic sequences of the adeno-associated virus terminal repeat. Virology 166, 316-27.
6. CARTER, B.J. (1992). Adeno-associated virus vectors. Curr. Opinion Biotechnol. 3, 533-539.
7. CASSINOTTI, P., WEITZ, M., and TRATSCHIN, J.D. (1988). Organization of the adeno-associated virus (AAV) capsid gene: Mapping of a minor spliced mRNA coding for virus capsid protein 1. Virology 167, 176-84.
8. CHANG, L.S., SHI, Y., and SHENK, T. (1989). Adeno-associated virus P5 promoter contains an adenovirus E1A-inducible element and a binding site for the major late transcription factor. J. Virol. 63, 3479-3488.
9. CHATTERJEE, S., JOHNSON, P R., and WONG, K.J. (1992). Dualtarget inhibition of HIV-1 in vitro by means of an adeno-associated virus antisense vector Science 258, 1485-1488.
10. CHEJANOVSKY, N., and CARTER, B.J. (1989). Replication of a human parvovirus nonsense mutant in mammalian cells containing an inducible amber suppressor. Virology 171, 239-47.
11. CHEUNG, A.K., HOGGAN, M.D., HAUSWIRTH, W.W., and BERNS, K.I. (1980). Integration of the adeno-associated virus genome into cellular DNA in latently infected human Detroit 6 cells. J Virol. 33, 739-748
12. CHIORINI, J.A., WEITZMAN, M.D., OWENS, R.A., URCELAY, E., SAFER, B., and KOTIN, R.M. (1994). Biologically active Rep proteins of adeno-associated virus type 2 produced as fusion proteins in Escherichla coli. J. Virol. 68, 797-804.
13. FLOTTE, T R., AFIONE, S.A., CONRAD, C., MCGRATH, S.A., SOLOW, R., OKA, H., ZEITLIN, P.L., GUGGINO, W.B., and CARTER, B.J. (1993a). Stable in vivo expression of the cystic fibrosis transmembrane regulator with an adeno-associated virus vector. Proc. Natl. Acad. Sci. USA 90, 10613-10617.
14. FLOTTE, T.R., AFIONE, S.A., SOLOW, R., DRUMM, M.L., MARKAKIS, D., GUGGINO, W.B., ZEITLIN, P.L., and CARTER, B.J. (1993b). Expression of the cystic fibrosis transmembrane conductance regulator from a novel adeno-associated virus promoter. J. Biol. Chem. 268, 3781-3790,
15. HANDA, H., SHIROKI, K., and SHIMOJO, H. (1977). Establishment and characterization of KB cell lines latently infected with adeno-associated virus type I. Virology 82, 84-92.
16. HERMONAT, P.L, LABOW, M.A., WRIGHT, R., BERNS, K.I., and MUZYCZKA, N. (1984). Genetics of adeno-associated virus: Isolation and preliminary characterization of adeno-associated type 2 mutants. J. Virol. 51, 329-339.
17. HOGGAN, M.D., THOMAS, G F., THOMAS, F.B., and JOHNSON, F.B. (1972) Continuous carriage of adenovirus associated virus genome in cell culture in the absence of helper adenovirus. In Proceedings of the Fourth Lepetite Colloquium, Cocoyac, Mexico (North-Holland, Amsterdam) pp. 243-249
18. IM, D.-S., and MUZYCZKA, N. (1990). The AAV origin binding protein is an ATP-dependent site-specific endonuclease with DNA helicase activity. Cell 61, 447-457.
19. JANIK, J.E., HUSTON, M.M., CHO, K., and ROSE, J.A. (1989). Efficient synthesis of adeno-associated virus structural proteins requires both adenovirus DNA binding protein and VA I RNA. Virology 168, 320-329.
20. JAY, FT., DE LA MAZA, L.M , and CARTER, B.J. (1979). Parvovirus RNA transcripts containing sequences not present in mature mRNA: A method for isolation of putative mRNA precursor sequences. Proc. Natl Acad Sci. USA 76, 625-629.
21. KOTIN, R.M., and BERNS, K.I. (1989). Organization of adeno-associated virus DNA in latently infected Detroit 6 cells. Virology 170, 460-467
22. KOTIN, R.M, SINISCALCO, M., SAMULSKI, R.J., ZHU, X., HUNTER, L., LAUGHLIN, C.A., MCLAUGHLIN, S., MUZYCZKA, N., ROCCHI, M., and BERNS, K.I. (1990). Site-specific integration by adeno-associated virus. Proc. Natl. Acad. Sci USA 87, 2211-2215.
23. KOTIN, R.M., MENNINGER, J.C., WARD, D.C., and BERNS, K.I. (1991). Mapping and direct visualization of a region-specific viral DNA integration site on chromosome 19q13-qter. Genomics 10, 831-834.
24. KOTIN, R.M., LINDEN, R.M., and BERNS, K.J. (1992). Characterization of a preferred site on human chromosome 19q for integration of adeno-associated virus DNA by non-homologous recombination. EMBO J. 11, 5071-5078.
25. KUMAR, S., and LEFFAK, M. (1991). Conserved chromatin structure in c-myc 5′-flanking DNA after viral transduction. J. Mol. Biol. 222, 45-57
26. LABOW, M.A., and BERNS, K.I. (1988). The adeno-associated virus rep gene inhibits replication of an adeno-associated virus/simian virus 40 hybrid genome in cos-7 cells. Mol. Cell. Biol 7, 1320-1325.
27. LABOW, M.A., HERMONAT. P.L., and BERNS, K.I. (1986). Positive and negative autoregulation of the adeno-associated virus type 2 genome. J. Virol. 60, 515-524.
28. LAFACE, D., HERMONAT, P., WAKELAND, E., and PECK, A. (1988). Gene transfer into hematopoietic progenitor cells mediated by an adeno-associated virus vector. Virology 162, 483-486.
29. LAUGHLIN, C.A., TRATSCHIN, J.D., COON, H., and CARTER, B.J. (1983) Cloning of infectious adeno-associated virus genomes in bacterial plasmids. Gene 23, 65-73
30. LAUGHLIN, C.A., CARDELLICHIO, C.B., and COON, H.C. (1986). Latent infection of KB cells with adeno-associated virus type 2. J Virol. 60, 515-524.
31. LEBKOWSKI, J.S., MCNALLY, M.A., and OKARMA. T.B. (1992). "Production of recombinant adeno-associated virus vectors." United States Patent 5, 173, 414.
32. LEBKOWSKI, J.S., MCNALLY, M., OKARMA, T.B., and LERCH, L.B. (1988). Adeno-associated virus: A vector system for efficient introduction and integration of DNA into a variety of mammalian cells. Mol. Cell. Biol. 8, 3988-3996.
33. LEBKOWSKI, J, PAGE, K., MCNALLY, M., BERSON. A., PHILIP. R., and OKARMA, T.B. (1993). Adeno-associated virus: A vector for high-efficiency transduction of primary cells (abstract). Cancer Gene Ther. 1 (suppl. 1), 6.
34. LEFEBVRE, R B., and BERNS, K.I. (1984). Unique events in parvovirus replication. Microbiol. Sci. 1, 163-167.
35. LUO, F., ZHOU. S.Z., COOPER, S., MUNSKI, N.C., BOSWELL, H.S., BROXMEYER, H.E., and SRIVASTAVA, A. Adeno-associated virus 2-mediated transfer and functional expression of a gene encoding the human granulocyte-macrophage colony-stimulating factor (abstract) In American Society of Hematology, St. Louis, MO, 303a, 1993.
36. MCLAUGHLIN, S.K., COLLIS, P., HERMONAT, P.L., and MUZYCZKA, N (1988). Adeno-associated virus general transduction vectors: analysis of proviral structures. J. Virol. 62, 1963-1973.
37. MILLER, A.D. (1992) Retrovirus vectors. Curr. Topics Microbiol Immunol 158, 1-24.
38. MILLER. J.L, WALSH, C.E., NEY, P.A, SAMULSKI, R.J., and NIENHUIS, A.W. (1993). Single-copy transduction and expression of human gamma-globin in K562 erythroleukemia cells using recombinant adeno-associated virus vectors: The effect of mutations in NF-E2 and GATA-1 binding motifs within the hypersensitivity site 2 enhancer. Blood 82, 1900-1906.
39. MILLER, J.L., WALSH, C.E, SAMULSKI, R.J., YOUNG, N.S., and NIENHUIS, A.W. Transfer and expression of the human γ globin gene in purified hematopoeitic progenitor cells from Rhesus bone marrow using a recombinant adeno-associated viral (rAAV) vector (abstract). In Fifth Parvovirus Workshop, Crystal River, FL, 1993b.
40. MORGAN, R. (1994). Retroviral vectors in human gene therapy. In Viruses in Human Gene Therapy. J.M Vos, ed. (Carolina Academic Press, Durham, NC), pp. 77-107.
41. MURO-CACHO, C., SAMULSKI, R.J, and KAPLAN, D. (1992). Gene transfer in human lymphocytes using a vector based on adenoassociated virus. J. Immunother. 11, 231-237.
42. MUZYCZKA, N. (1992) Use of adeno-associated virus as a general transduction vector for mammalian cells. Curr. Top. Microbiol. Immunol. 158, 97-129.
43. NI, T.-H., ZHOU, X., MCCARTY, D., ZOLOTUKHIN, I., and MUZYCZKA, N. (1994). In vitro replication of adeno-associated virus DNA. J. Virol 68, 1128-1138.
44. PONNAZHAGAN, S., NALLARI, M.L., and SRIVASTAVA, A Suppression of human α-globin gene expression mediated by the recombinant adeno-associated virus 2-based anti-sense vectors (abstract). In American Society of Hematology, St. Louis, MO, 303a, 1993.
45. RICHARDSON, W.D., and WESTPHAL, H. (1981). A cascade of adenovinis early functions is required for expression of adeno-associated virus. Cell 27, 133-141.
46. RICHARDSON, W.D., and WESTPHAL, H. (1984). Requirement for either early region la or early region 1b adenovirus gene products in the helper effect for adeno-associated virus. J. Virol. 51, 404-410
47. RICHARDSON, W.D., CARTER, B.J., and WESTPHAL, H. (1980). Vero cells injected with adenovirus type 2 mRNA produce authentic viral polypeptide patterns: early mRNA promoted growth of adenovirus-associated virus. Proc. Natl. Acad. Sci. USA 77, 931-935.
48. ROSE, J.A.., MAIZEL, J.K., and SHATKIN, A.I. (1971). The structural proteins of adenovirus-associated virus. J. Virol. 8, 766-770.
49. RUFFING, M., ZENTGRAF, H., and KLEINSCHMIDT, J.A. (1992). Assembly of viruslike particles by recombinant structural proteins of adeno-associated virus type 2 in insect cells. J. Virol. 66, 6922-6930.
50. RYNDITCH, A., KADI, F., GERYK, J., ZOUBAK, S., SVOBODA, J., and BERNARDI, G. (1991) The isopyenic, compartmentalized integration of Rous sarcoma virus sequences. Gene 106, 165-172.
51. SAMULSKI, R.J., BERNS. K.I., TAN, M, and MUZYCZKA, N. (1982). Cloning of adeno-associated virus into pBR322: Rescue of intact virus from the recombinant plasmid in human cells. Proc. Natl. Acad. Sci. USA 79, 2077-2081.
52. SAMULSKI, R.J., CHANO, L.S., and SHENK, T. (1989). Helperfree stocks of recombinant adeno-associated viruses: Normal integration does not require viral gene expression. J. Virol. 63, 3822-3828.
53. SAMULSKI, R.J., ZHU, X., XIAO, X., BROOK, J.D., HOUSMAN, D.E., EPSTEIN, N., and HUNTER, L.A. (1991). Targeted integration of adeno-associated virus (AAV) into human chromosome 19. [Published erratum appears in EMBO J. 1992, Mar 11 (3):1228.]. EMBO J 10, 3941-3950
54. SHELLING, A., and SMITH, M.G. (1994). Targeted integration of transfected and infected adeno-associated virus vectors containing the neomycin resistance gene. Gene Therapy 1, 165-169.
55. SHIH, C.-C., STOYE, J.P., and COFFIN, J M. (1989). Highly preferred targets for retroviral integration. Cell 53, 531-537.
56. SRIVASTAVA, A., LUSBY, E.W., and BERNS. K.I. (1983). Nucleotide sequence and organization of the adeno-associated virus 2 genome. J. Virol. 45, 555-564.
57. TREMPE, J.P., and CARTER, B.J. (1988): Alternate mRNA splicing is required for synthesis of adeno-associated virus VP1 capsid protein. J. Virol. 62, 3356-3363.
58. TREMPE, J.P., and YANG, Q. Characterization of a cell line that expresses the AAV replication proteins (abstract). In Fifth Parvovirus Workshop. Crystal River, FL., 5-3, 1993
59. VINCENT, K.A., MOORE, G.K., and HAIGWOOD, N.L. (1990). Replication and packaging of HIV envelope genes in a novel adenoassociated virus vector system. In Vaccines 90. (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY) pp. 353-359.
60. WALSH, C.E., NIENHUIS, A.W., SAMULSKI, R.J., MILLER, J.L., YOUNG, N.S., and LIU. J.M. Phenotypic correction of fanconi anemia (FACC) in lymphoblasts and CD34+ progenitors with a recombinant adeno-associated virus (rAAV) vector (abstract). In American Society of Hematology, St. Louis, MO, 345a, 1993.
61. WEITZMAN, M.D., KYOSTIO, S.R.M., KOTIN, R.M., and OWENS, R.A. (1994). Adeno-associated virus (AAV) rep proteins mediate comple formation between AAV DNA and the human integration site. Proc. Natl Acad. Sci. USA 91, in press.
62. WEST, M.H., TREMPE, J.P., TRATSCHIN, J.D.. and CARTER, B.J (1987) Gene expression in adeno-associated virus vectors: The effects of chimeric mRNA structure, helper virus, and adenovirus VA1 RNA. Virology 160, 38-47
63. WONG, K.K., PODSAKOFF, G., LU, D., and CHATTERJEE, S. High efficiency gene transfer into growth arrested cells utilizing an adeno-associated virus (AAV)-based vector (abstract) In American Society of Hematology, St. Louis, MO, 302a, 1993.
64. ZHOU, S.Z., BROXMEYER, H.E., COOPER, S., HARRINGTON, MA., and SRIVASTAVA, A. (1993). Adeno-associated virus 2-mediated gene transfer in murine hematopoietic progenitor cells. Exp Hematol. 21, 928-933.